Načítá se...
Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights
Hepatocellular cancer is the 5(th) most common cancer in the world and the third cause of death by malignant disease. Locoregional therapies are the most usual treatment of choice for patients with early or intermediate stage of disease. The main diagnostic tools for the detection of recurrence are...
Uloženo v:
| Vydáno v: | World J Hepatol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4506941/ https://ncbi.nlm.nih.gov/pubmed/26207165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i14.1834 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|